Showing results (1351-1360 of 2,900) with videos related to

Sort By:
Pageof 290
Molecular and Clinical Oncology|January 24, 2022
Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRIAkifumi Kuwano, Kosuke Tanaka, Masayoshi Yada, et al.
International Surgery|January 30, 2010
Laparoscopic cholecystectomy using a novel two-port technique for surgical residency trainingTatsuo Shimura, Taketoshi Suehiro, Hideki Suzuki, et al.
Journal of Equine Veterinary Science|May 20, 2023
Characteristic Inflammatory Biomarkers in an Equine Model of Persistent Synovitis Induced By the Intra-Articular Administration of Monoiodoacetic AcidKentaro Fukuda, Hiroshi Mita, Norihisa Tamura, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|August 9, 2022
[A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis]Yusuke Morita, Akifumi Kuwano, Shigehiro Nagasawa, et al.
Anticancer Research|September 26, 2025
Cost-effectiveness Analysis of Atezolizumab Plus Bevacizumab <i>Versus</i> Lenvatinib in Intermediate-stage Hepatocellular Carcinoma: A Real-world Retrospective StudyAkifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Biochimica Et Biophysica Acta|August 2, 1983
Developmental changes in the translatable mRNA for beta subunit of S-100 protein in rat brainT Masuda, K Sakimura, Y Yoshida, et al.
Biochemistry International|October 1, 1987
ID sequences in the genes of three brain-specific proteinsH Usui, R Kuwano, T Maeda, et al.
In Vivo (Athens, Greece)|June 27, 2024
Similar Efficacy Between Atezolizumab Plus Bevacizumab <i>Versus</i> Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort StudyAkifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Experimental and Therapeutic Medicine|August 24, 2023
FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapyAkifumi Kuwano, Masayuki Miyazaki, Masayoshi Yada, et al.
Cancer Diagnosis & Prognosis|January 4, 2024
Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabAkifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Pageof 290